Harris Kaplan Featured on Citeline's In Vivo Podcast: The Yescarta Launch Examined

Harris Kaplan, Founder and Managing Partner of Litmys, joined Diane Parks, former Senior Vice President and Head of Cell Therapy at Kite Pharma, and Jim Haag, a CAR-T therapy recipient, for a Citeline In Vivo podcast discussion examining the launch of Yescarta.

Hosted by David Wild, the conversation explores the scientific, commercial, and patient-centered factors that helped shape one of the most significant advances in cell therapy. Bringing together perspectives from industry leadership, commercialization, and lived patient experience, the discussion provides valuable perspective on the relationship between clinical innovation, market access, stakeholder adoption, and long-term commercial performance, while offering broader lessons for biotechnology companies seeking to translate scientific innovation into commercial success.

Listen to or watch the full episode on Citeline's In Vivo podcast, Spotify, or Apple Podcasts.

.